Publications by authors named "Emma Nimeus"

Claim this Profile
T
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial.
Axel Stenmark Tullberg, Viktoria Thurfjell, Anikó Kovács, Patrick Micke, Aristidis Moustakas

Breast Cancer Res Treat· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human proteome distribution atlas for tissue-specific plasma proteome dynamics.
Erik Malmström, Lars Malmström, Simon Hauri, Tirthankar Mohanty, Aaron Scott

Cell· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort.
Gudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, Johan Hartman, Susann Ullén

Breast Cancer Res Treat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.
Rebecca J G Drake, Amalia H Landén, Erik Holmberg, Axel Stenmark Tullberg, Fredrika Killander

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose-6-phosphate-dehydrogenase on old peroxisomes maintains self-renewal of epithelial stem cells after asymmetric cell division.
Hien Bui, Simon Andersson, Agustin Sola-Carvajal, Tommaso De Marchi, Eliisa Vähäkangas

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up.
Moa Egelberg, Tommaso De Marchi, Niklas Schultz, Lena Tran, Per Karlsson

BMC Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Nimeus

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling.
Tommaso De Marchi, Chun-Fui Lai, Georgia M Simmons, Isabella Goldsbrough, Alison Harrod

Sci Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.
Moa Egelberg, Tommaso De Marchi, Gyula Pekar, Lena Tran, Pär-Ola Bendahl

Mol Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms.
Gudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, Johan Hartman, Ana Bosch

Breast Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander, S Laura Chang

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.
Axel Stenmark Tullberg, Martin Sjöström, Lena Tran, Emma Niméus, Fredrika Killander

J Immunother Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteogenomics decodes the evolution of human ipsilateral breast cancer.
Tommaso De Marchi, Paul Theodor Pyl, Martin Sjöström, Susanne Erika Reinsbach, Sebastian DiLorenzo

Commun Biol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics.
Ugo Chianese, Chiara Papulino, Eugenia Passaro, Tom Mj Evers, Mehrad Babaei

Mol Metab· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up.
Julia Tutzauer, Martin Sjöström, Erik Holmberg, Per Karlsson, Fredrika Killander

Br J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A somatic mutation in moesin drives progression into acute myeloid leukemia.
Ouyang Yuan, Amol Ugale, Tommaso de Marchi, Vimala Anthonydhason, Anna Konturek-Ciesla

Sci Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.
Yalai Bai, Kimberly Cole, Sandra Martinez-Morilla, Fahad Shabbir Ahmed, Jon Zugazagoitia, Emma Nimeus

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
Kristina Åhsberg, Anna Gardfjell, Emma Nimeus, Lisa Ryden, Sophia Zackrisson

BMC Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance.
Tommaso De Marchi, Paul Theodor Pyl, Martin Sjöström, Stina Klasson, Hanna Sartor

J Proteome Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial.
Axel Stenmark Tullberg, Henri A J Puttonen, Martin Sjöström, Erik Holmberg, S Laura Chang

Clin Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer.
Rosaria Benedetti, Chiara Papulino, Giulia Sgueglia, Ugo Chianese, Tommaso De Marchi

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular analyses of triple-negative breast cancer in the young and elderly.
Mattias Aine, Ceren Boyaci, Johan Hartman, Jari Häkkinen, Shamik Mitra, Emma Nimeus

Breast Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly.
Mattias Aine, Ceren Boyaci, Johan Hartman, Jari Häkkinen, Shamik Mitra, Emma Nimeus

Breast Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery: a long-term follow-up of the SweBCG91-RT randomised trial.
Martin Sjöström, Cynthia Veenstra, Erik Holmberg, Per Karlsson, Fredrika Killander

Mol Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers.
Dominik Glodzik, Ana Bosch, Johan Hartman, Mattias Aine, Johan Vallon-Christersson

Nat Commun· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis